Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 67 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

EDITORIAL

Bedaquiline: First FDA-approved tuberculosis drug in 40 years

Mahajan Rajiv

Year : 2013| Volume: 3| Issue : 1 | Page no: 1-2

   This article has been cited by
 
1 Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method
Pankul Kotwal,Asmita Magotra,Ashish Dogra,Sumit Sharma,Abhishek Gour,Shipra Bhatt,Priya Wazir,Parvinder Pal Singh,Gurdarshan Singh,Utpal Nandi
Journal of Chromatography B. 2019; 1112: 48
[Pubmed]  [Google Scholar] [DOI]
2 Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors
Harun Patel,Harsha Jadhav,Iqrar Ansari,Rahul Pawara,Sanjay Surana
European Journal of Medicinal Chemistry. 2019; 167: 1
[Pubmed]  [Google Scholar] [DOI]
3 Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB
Kaksha Sankhe,Tabassum Khan,Chintan Bhavsar,Munira Momin,Abdelwahab Omri
Expert Opinion on Drug Delivery. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Antitubercular metabolites from the marine-derived fungus strain Aspergillus fumigatus MF029
Zhijun Song,Yu Liu,Jieyu Gao,Jiansen Hu,Hongtao He,Shengwang Dai,Luoqiang Wang,Huanqin Dai,Lixin Zhang,Fuhang Song
Natural Product Research. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Azaaurones as Potent Antimycobacterial Agents Active against MDR- and XDR-TB
André Campaniço,Marta P. Carrasco,Mathew Njoroge,Ronnett Seldon,Kelly Chibale,João Perdigão,Isabel Portugal,Digby F. Warner,Rui Moreira,Francisca Lopes
ChemMedChem. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen
Arundhati Maitra,Tulika Munshi,Jess Healy,Liam T Martin,Waldemar Vollmer,Nicholas H Keep,Sanjib Bhakta
FEMS Microbiology Reviews. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Synthesis and Study of New Quinolineaminoethanols as Anti-Bacterial Drugs
J.W.C. Laumaillé,J.W.C. Dassonville-Klimpt,J.W.C. Peltier,J.W.C. Mullié,J.W.C. Andréjak,J.W.C. Da-Nascimento,J.W.C. Castelain,J.W.C. Sonnet
Pharmaceuticals. 2019; 12(2): 91
[Pubmed]  [Google Scholar] [DOI]
8 Structural simplification: an efficient strategy in lead optimization
Shengzheng Wang,Guoqiang Dong,Chunquan Sheng
Acta Pharmaceutica Sinica B. 2019;
[Pubmed]  [Google Scholar] [DOI]
9 Total Synthesis and Conformational Study of Callyaerin A: Anti-Tubercular Cyclic Peptide Bearing a Rare Rigidifying (Z )-2,3- Diaminoacrylamide Moiety
Shengping Zhang,Luis M. De Leon Rodriguez,Ivanhoe K. H. Leung,Gregory M. Cook,Paul W. R. Harris,Margaret A. Brimble
Angewandte Chemie International Edition. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Total Synthesis and Conformational Study of Callyaerin A: Anti-Tubercular Cyclic Peptide Bearing a Rare Rigidifying (Z )-2,3- Diaminoacrylamide Moiety
Shengping Zhang,Luis M. De Leon Rodriguez,Ivanhoe K. H. Leung,Gregory M. Cook,Paul W. R. Harris,Margaret A. Brimble
Angewandte Chemie. 2018;
[Pubmed]  [Google Scholar] [DOI]
11 Scientific rationale for traditional use of plants to treat tuberculosis in the eastern region of the OR Tambo district, South Africa
B. Madikizela,L.J. McGaw
Journal of Ethnopharmacology. 2018; 224: 250
[Pubmed]  [Google Scholar] [DOI]
12 Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation
Vincent Shalini,Albertus Viljoen,Laurent Kremer,Vipan Kumar
Bioorganic & Medicinal Chemistry Letters. 2018;
[Pubmed]  [Google Scholar] [DOI]
13 In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex
Barbara A. Brown-Elliott,Richard J. Wallace
Antimicrobial Agents and Chemotherapy. 2018; 63(2): e01919-18
[Pubmed]  [Google Scholar] [DOI]
14 Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives
Saleha Banu,Rajitha Bollu,Lingaiah Nagarapu,Jagadeesh Babu Nanubolu,Perumal Yogeswari,Dharmarajan Sriram,Shravan Kumar Gunda,Divyasphoorthi Vardhan
Chemical Biology & Drug Design. 2018;
[Pubmed]  [Google Scholar] [DOI]
15 Mycobacterial protein tyrosine kinase, PtkA phosphorylates PtpA at tyrosine residues and the mechanism is stalled by the novel series of inhibitors
Swati Jaiswal,Aditi Chatterjee,Sapna Pandey,Kiran Lata,Ranjith Kumar Gadi,Rajesh Manda,Sanjay Kumar,Maddi Sridhar Reddy,Ravishankar Ramachandran,Kishore K. Srivastava
Journal of Drug Targeting. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
16 Rational design of isonicotinic acid hydrazide derivatives with antitubercular activity: Machine learning, molecular docking, synthesis and biological testing
Vasyl Kovalishyn,Julie Grouleff,Ivan Semenyuta,Vitaliy O. Sinenko,Sergiy R. Slivchuk,Diana Hodyna,Volodymyr Brovarets,Volodymyr Blagodatny,Gennady Poda,Igor V. Tetko,Larysa Metelytsia
Chemical Biology & Drug Design. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit C
Maxime Lamontagne Boulet,Charles Isabelle,Isabelle Guay,Eric Brouillette,Jean-Philippe Langlois,Pierre-Étienne Jacques,Sébastien Rodrigue,Ryszard Brzezinski,Pascale B. Beauregard,Kamal Bouarab,Kumaraswamy Boyapelly,Pierre-Luc Boudreault,Éric Marsault,François Malouin
Antimicrobial Agents and Chemotherapy. 2018; 62(6): e02197-17
[Pubmed]  [Google Scholar] [DOI]
18 Ultrasound Assisted Synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) Benzamide as Challenging Anti-Tubercular Scaffold
Urja Nimbalkar,Julio Seijas,Rachna Borkute,Manoj Damale,Jaiprakash Sangshetti,Dhiman Sarkar,Anna Nikalje
Molecules. 2018; 23(8): 1945
[Pubmed]  [Google Scholar] [DOI]
19 Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
Diana Machado,Miriam Girardini,Miguel Viveiros,Marco Pieroni
Frontiers in Microbiology. 2018; 9
[Pubmed]  [Google Scholar] [DOI]
20 Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach
Ramón Soto,Esther Perez-Herran,Beatriz Rodriguez,Bogdan M. Duma,Monica Cacho-Izquierdo,Alfonso Mendoza-Losana,Joel Lelievre,David Barros Aguirre,Lluis Ballell,Liam R. Cox,Luke J. Alderwick,Gurdyal S. Besra
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
21 Slow-Binding Inhibition of Mycobacterium tuberculosis Shikimate Kinase by Manzamine Alkaloids
Johayra Simithy,Ngolui Rene Fuanta,Mansour Alturki,Judith V. Hobrath,Amir E. Wahba,Ivett Pina,Jnanendra Rath,Mark T. Hamann,Jack DeRuiter,Douglas C. Goodwin,Angela I. Calderón
Biochemistry. 2018; 57(32): 4923
[Pubmed]  [Google Scholar] [DOI]
22 Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Conjugated Quinazoline-Sulfonamide Scaffold
A. Sunil Kumar,Jyothi Kudva,B. R. Bharath,Vaishali M Rai,S. Madan Kumar,Vasantha Kumar,Shyama Prasad Sajankila
ChemistrySelect. 2018; 3(48): 13586
[Pubmed]  [Google Scholar] [DOI]
23 In vitro activity of collinin isolated from the leaves of Zanthoxylum schinifolium against multidrug- and extensively drug-resistant Mycobacterium tuberculosis
Sukyung Kim,Hoonhee Seo,Hafij Al Mahmud,Md Imtiazul Islam,Byung-Eui Lee,Myoung-Lae Cho,Ho-Yeon Song
Phytomedicine. 2018;
[Pubmed]  [Google Scholar] [DOI]
24 Bedaquiline- versus injectable-containing drug-resistant tuberculosis regimens: a cost-effectiveness analysis
Ana-Maria Ionescu,Abela Mpobela Agnarson,Chrispin Kambili,Laurent Metz,Jonathan Kfoury,Steven Wang,Abeda Williams,Vikram Singh,Adrian Thomas
Expert Review of Pharmacoeconomics & Outcomes Research. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
25 Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy
Julie Laborde,Céline Deraeve,Francisca Gilmara de Mesquita Vieira,Alix Sournia-Saquet,Lionel Rechignat,Anne Drumond Villela,Bruno Lopes Abbadi,Fernanda Souza Macchi,Kenia Pissinate,Cristiano V. Bizarro,Pablo Machado,Luiz Augusto Basso,Geneviève Pratviel,Luiz Gonzaga de França Lopes,Eduardo Henrique Silva Sousa,Vania Bernardes-Génisson
Journal of Inorganic Biochemistry. 2018; 179: 71
[Pubmed]  [Google Scholar] [DOI]
26 Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H -1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis
Navnath D. Rode,Amol D. Sonawane,Laxman Nawale,Vijay M. Khedkar,Ramesh A. Joshi,Anjali P. Likhite,Dhiman Sarkar,Rohini R. Joshi
Chemical Biology & Drug Design. 2017;
[Pubmed]  [Google Scholar] [DOI]
27 Trends in the discovery of new drugs for Mycobacterium tuberculosis therapy with a glance at resistance
Vahid Lohrasbi,Malihe Talebi,Abed Zahedi Bialvaei,Lanfranco Fattorini,Michel Drancourt,Mohsen Heidary,Davood Darban-Sarokhalil
Tuberculosis. 2017;
[Pubmed]  [Google Scholar] [DOI]
28 Genomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Rinat A. Islamov,Gulshara K. Akhmetova,Marina V. Lankina,Oleg N. Reva
Frontiers in Cellular and Infection Microbiology. 2017; 7
[Pubmed]  [Google Scholar] [DOI]
29 Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
Ji-Chan Jang,Yong-Gyun Jung,Jungil Choi,Hyunju Jung,Sungweon Ryoo
Journal of Microbiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
30 A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations
Alexander D. Giddey,Elise de Kock,Kehilwe C. Nakedi,Shaun Garnett,Andrew J. M. Nel,Nelson C. Soares,Jonathan M. Blackburn
Scientific Reports. 2017; 7: 43858
[Pubmed]  [Google Scholar] [DOI]
31 Synthesis, molecular docking, antimycobacterial and antimicrobial evaluation of new pyrrolo[3,2- c ]pyridine Mannich bases
Gilish Jose,Tholappanavara H. Suresha Kumara,Haliwana B.V. Sowmya,Dharmarajan Sriram,Tayur N. Guru Row,Amar A. Hosamani,Sunil S. More,Bhavya Janardhan,B.G. Harish,Sandeep Telkar,Yalegara Siddappa Ravikumar
European Journal of Medicinal Chemistry. 2017; 131: 275
[Pubmed]  [Google Scholar] [DOI]
32 Tuberculosis: Still a Way to go ahead for a Lead- A Review
Priyanka Bose,Amit K Harit,Kamal Krishna Halder
Journal of Analytical & Pharmaceutical Research. 2017; 5(6)
[Pubmed]  [Google Scholar] [DOI]
33 Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery
Elisa Azzali,Diana Machado,Amit Kaushik,Federica Vacondio,Sara Flisi,Clotilde Silvia Cabassi,Gyanu Lamichhane,Miguel Viveiros,Gabriele Costantino,Marco Pieroni
Journal of Medicinal Chemistry. 2017;
[Pubmed]  [Google Scholar] [DOI]
34 Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’
Yoshiaki Takahashi,Masayuki Igarashi
The Journal of Antibiotics. 2017;
[Pubmed]  [Google Scholar] [DOI]
35 Synergistic Response of Rifampicin with Hydroperoxides on Mycobacterium: A Mechanistic Study
Yesha S. Patel,Sarika Mehra
Frontiers in Microbiology. 2017; 8
[Pubmed]  [Google Scholar] [DOI]
36 High-Content Screening of Raw Actinomycete Extracts for the Identification of Antituberculosis Activities
Jinyeong Heo,Jiyoun Nam,Jichan Jang,David Shum,Constantin Radu,Jinhua Cheng,Hanki Lee,Joo-Won Suh,Vincent Delorme
SLAS Discovery. 2017; 22(2): 144
[Pubmed]  [Google Scholar] [DOI]
37 Constraints of Drug Resistance in Mycobacterium tuberculosis - Prospects for Pharmacological Reversion of Susceptibility to Antibiotics
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Marina V. Lankina,Gulshara K. Akhmetova,Sergey V. Shvidko,Oleg N. Reva
The Open Conference Proceedings Journal. 2017; 8(1): 33
[Pubmed]  [Google Scholar] [DOI]
38 Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains
Ziqiang Li,Xiaoguang Bai,Qi Deng,Guoning Zhang,Lei Zhou,Yishuang Liu,Juxian Wang,Yucheng Wang
Bioorganic & Medicinal Chemistry. 2017; 25(1): 213
[Pubmed]  [Google Scholar] [DOI]
39 Discovery of in vitro antitubercular agents through in silico ligand-based approaches
Daniela De Vita,Fabiana Pandolfi,Roberto Cirilli,Luigi Scipione,Roberto Di Santo,Laura Friggeri,Mattia Mori,Diego Fiorucci,Giorgio Maccari,Robert Selwyne Arul Christopher,Claudio Zamperini,Valentina Pau,Alessandro De Logu,Silvano Tortorella,Maurizio Botta
European Journal of Medicinal Chemistry. 2016; 121: 169
[Pubmed]  [Google Scholar] [DOI]
40 N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-transEnoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity
Ana Guardia,Gulcin Gulten,Raquel Fernandez,Jesus Gómez,Feng Wang,Maire Convery,Delia Blanco,María Martínez,Esther Pérez-Herrán,Marta Alonso,Fátima Ortega,Joaquín Rullás,David Calvo,Lydia Mata,Robert Young,James C. Sacchettini,Alfonso Mendoza-Losana,Modesto Remuiñán,Lluís Ballell Pages,Julia Castro-Pichel
ChemMedChem. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
41 Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials
Riya Moodley,Thomas R. Godec
European Respiratory Review. 2016; 25(139): 29
[Pubmed]  [Google Scholar] [DOI]
42 Scaffold morphing leading to evolution of 2,4-diaminoquinolines and aminopyrazolopyrimidines as inhibitors of the ATP synthesis pathway
Subramanyam J. Tantry,Vikas Shinde,Gayathri Balakrishnan,Shankar D. Markad,Amit K. Gupta,Jyothi Bhat,Ashwini Narayan,Anandkumar Raichurkar,Lalit Kumar Jena,Sreevalli Sharma,Naveen Kumar,Robert Nanduri,Sowmya Bharath,Jitendar Reddy,Vijender Panduga,K. R. Prabhakar,Karthikeyan Kandaswamy,Parvinder Kaur,Neela Dinesh,Supreeth Guptha,Ramanatha Saralaya,Manoranjan Panda,Suresh Rudrapatna,Meenakshi Mallya,Harvey Rubin,Takahiro Yano,Khisi Mdluili,Christopher B. Cooper,V. Balasubramanian,Vasan K. Sambandamurthy,Vasanthi Ramachandran,Radha Shandil,Stefan Kavanagh,Shridhar Narayanan,Pravin Iyer,Kakoli Mukherjee,Vinayak P. Hosagrahara,Suresh Solapure,Shahul Hameed P,Sudha Ravishankar
Med. Chem. Commun.. 2016;
[Pubmed]  [Google Scholar] [DOI]
43 Crystal structure ofMycobacterium tuberculosisketol-acid reductoisomerase at 1.0 Å resolution - a potential target for anti-tuberculosis drug discovery
You Lv,Ajit Kandale,Shun Jie Wun,Ross P. McGeary,Simon J. Williams,Bostjan Kobe,Volker Sieber,Mark A. Schembri,Gerhard Schenk,Luke W. Guddat
FEBS Journal. 2016; 283(7): 1184
[Pubmed]  [Google Scholar] [DOI]
44 Viability, morphology, and proteome ofMycobacterium smegmatis MSMEG_0319knockout strain
Shanshan Sha,Xiaoxia Shi,Liming Xu,Jiabin Wen,Yi Xin,Yufang Ma
PROTEOMICS. 2016; 16(7): 1090
[Pubmed]  [Google Scholar] [DOI]
45 Design, synthesis and biological evaluation of novel quinoline-based carboxylic hydrazides as anti-tubercular agents
Subhash Chander,Penta Ashok,Davie Cappoen,Paul Cos,Sankaranarayanan Murugesan
Chemical Biology & Drug Design. 2016;
[Pubmed]  [Google Scholar] [DOI]
46 Synthesis and antitubercular and antibacterial activity of some active fluorine containing quinoline–pyrazole hybrid derivatives
Nagabhushana Nayak,Jurupula Ramprasad,Udayakumar Dalimba
Journal of Fluorine Chemistry. 2016; 183: 59
[Pubmed]  [Google Scholar] [DOI]
47 The pregnane X receptor in tuberculosis therapeutics
Amina I Shehu,Guangming Li,Wen Xie,Xiaochao Ma
Expert Opinion on Drug Metabolism & Toxicology. 2016; 12(1): 21
[Pubmed]  [Google Scholar] [DOI]
48 Emerging drugs and alternative possibilities in the treatment of tuberculosis
S. Hofman,M.M. Segers,S. Ghimire,M.S. Bolhuis,M.G.G. Sturkenboom,D. Van Soolingen,J.W.C. Alffenaar
Expert Opinion on Emerging Drugs. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]
49 Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism
Julie Laborde,Céline Deraeve,Léa Lecoq,Alix Sournia-Saquet,Jean-Luc Stigliani,Beatrice S. Orena,Giorgia Mori,Geneviève Pratviel,Vania Bernardes-Génisson
ChemistrySelect. 2016; 1(2): 172
[Pubmed]  [Google Scholar] [DOI]
50 Identification of a novel class of quinoline–oxadiazole hybrids as anti-tuberculosis agents
Puneet P. Jain,Mariam S. Degani,Archana Raju,Aarti Anantram,Madhav Seervi,Sadhana Sathaye,Muktikanta Ray,M.G.R. Rajan
Bioorganic & Medicinal Chemistry Letters. 2016; 26(2): 645
[Pubmed]  [Google Scholar] [DOI]
51 Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent
Mubarak H. Shaikh,Dnyaneshwar D. Subhedar,Manisha Arkile,Vijay M. Khedkar,Nandadeep Jadhav,Dhiman Sarkar,Bapurao B. Shingate
Bioorganic & Medicinal Chemistry Letters. 2016; 26(2): 561
[Pubmed]  [Google Scholar] [DOI]
52 Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors
Brahmam Medapi,Nikhila Meda,Pushkar Kulkarni,Perumal Yogeeswari,Dharmarajan Sriram
Bioorganic & Medicinal Chemistry. 2016; 24(4): 877
[Pubmed]  [Google Scholar] [DOI]
53 Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
Julie V. Philley,Richard J. Wallace,Jeana L. Benwill,Varsha Taskar,Barbara A. Brown-Elliott,Foram Thakkar,Timothy R. Aksamit,David E. Griffith
Chest. 2015; 148(2): 499
[Pubmed]  [Google Scholar] [DOI]
54 Current perspectives in drug discovery against tuberculosis from natural products
Joseph Mwanzia Nguta,Regina Appiah-Opong,Alexander K. Nyarko,Dorothy Yeboah-Manu,Phyllis G.A. Addo
International Journal of Mycobacteriology. 2015; 4(3): 165
[Pubmed]  [Google Scholar] [DOI]
55 Complete Genome Sequence of Multidrug-Resistant Clinical IsolateMycobacterium tuberculosis187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1
Aleksandr I. Ilin,Murat E. Kulmanov,Ilya S. Korotetskiy,Gulshara K. Akhmetova,Marina V. Lankina,Sergey V. Shvidko,Oleg N. Reva
Genome Announcements. 2015; 3(6): e01272-15
[Pubmed]  [Google Scholar] [DOI]
56 Bedaquiline and delamanid in tuberculosis
Susanna Esposito,Sonia Bianchini,Francesco Blasi
Expert Opinion on Pharmacotherapy. 2015; 16(15): 2319
[Pubmed]  [Google Scholar] [DOI]
57 Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents
Bharathkumar Inturi,Gurubasavaraj V. Pujar,Madhusudhan N. Purohit
Journal of Receptors and Signal Transduction. 2015; 35(5): 468
[Pubmed]  [Google Scholar] [DOI]
58 Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design
Marco Pieroni,Baojie Wan,Valentina Zuliani,Scott G. Franzblau,Gabriele Costantino,Mirko Rivara
European Journal of Medicinal Chemistry. 2015; 100: 44
[Pubmed]  [Google Scholar] [DOI]
59 Design, Synthesis, and Biological Evaluation of New 8-Trifluoromethylquinoline Containing Pyrazole-3-carboxamide Derivatives
Nagabhushana Nayak,Jurupula Ramprasad,Udayakumar Dalimba
Journal of Heterocyclic Chemistry. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
60 Anything to Stay Alive: The Challenges of a Campaign for an Experimental Drug
Nathan Geffen
Developing World Bioethics. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
61 Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors
Manoj Chandran,Janupally Renuka,Jonnalagadda Padma Sridevi,Ganesh S. Pedgaonkar,Vanaparthi Asmitha,Perumal Yogeeswari,Dharmarajan Sriram
International Journal of Mycobacteriology. 2015;
[Pubmed]  [Google Scholar] [DOI]
62 Novel isoniazid–amidoether derivatives: synthesis, characterization and antimycobacterial activity evaluation
Deepak Kumar,Garima Khare,Beena Beena,Saqib Kidwai,Anil K. Tyagi,Ramandeep Singh,Diwan S. Rawat
Med. Chem. Commun.. 2015; 6(1): 131
[Pubmed]  [Google Scholar] [DOI]
63 Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen
Anita Ordas,Robert-Jan Raterink,Fraser Cunningham,Hans J. Jansen,Malgorzata I. Wiweger,Susanne Jong-Raadsen,Sabine Bos,Robert H. Bates,David Barros,Annemarie H. Meijer,Rob J. Vreeken,Lluís Ballell-Pages,Ron P. Dirks,Thomas Hankemeier,Herman P. Spaink
Antimicrobial Agents and Chemotherapy. 2015; 59(2): 753
[Pubmed]  [Google Scholar] [DOI]
64 Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
Isha Bhutani,Saurabh Loharch,Pawan Gupta,Rethi Madathil,Raman Parkesh,Chandra Verma
PLOS ONE. 2015; 10(3): e0119771
[Pubmed]  [Google Scholar] [DOI]
65 Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation
Deepak Kumar,Deepak Beena,Garima Khare,Saqib Kidwai,Anil K. Tyagi,Ramandeep Singh,Diwan S. Rawat
European Journal of Medicinal Chemistry. 2014;
[Pubmed]  [Google Scholar] [DOI]
66 TB Summit 2014: Prevention, diagnosis, and treatment of tuberculosis—a meeting report of a Euroscicon conference
Arundhati Maitra,Sanjib Bhakta
Virulence. 2014; 5(5): 638
[Pubmed]  [Google Scholar] [DOI]
67 Controlling strategy of dormant Mycobacterium tuberculosis
Gan Yiling,Guo Shuliang
Chinese Medical Journal. 2014; 127(18): 3316
[Pubmed]  [Google Scholar] [DOI]
68 Scaffold-switching: An exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates
Garrett C. Moraski,Allen G. Oliver,Lowell D. Markley,Sanghyun Cho,Scott G. Franzblau,Marvin J. Miller
Bioorganic & Medicinal Chemistry Letters. 2014;
[Pubmed]  [Google Scholar] [DOI]
69 Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues
Hunsur Nagendra Nagesh,Narva Suresh,Kalaga Mahalakshmi Naidu,Boyineni Arun,Jonnalagadda Padma Sridevi,Dharmarajan Sriram,Perumal Yogeeswari,Kondapalli Venkata Gowri Chandra Sekhar
European Journal of Medicinal Chemistry. 2014;
[Pubmed]  [Google Scholar] [DOI]
70 Design, synthesis and antimycobacterial activity of various 3-(4-(substitutedsulfonyl)piperazin-1-yl)benzo[d]isoxazole derivatives
Kalaga Mahalakshmi Naidu,Amaroju Suresh,Jayanty Subbalakshmi,Dharmarajan Sriram,Perumal Yogeeswari,Pallepogu Raghavaiah,Kondapalli Venkata Gowri Chandra Sekhar
European Journal of Medicinal Chemistry. 2014; 87: 71
[Pubmed]  [Google Scholar] [DOI]
71 Trends in discovery of new drugs for tuberculosis therapy
Giovanna Riccardi,Maria Rosalia Pasca
The Journal of Antibiotics. 2014;
[Pubmed]  [Google Scholar] [DOI]
72 Diagnosis and treatment of multidrug-resistant tuberculosis
Young Ae Kang
Journal of the Korean Medical Association. 2014; 57(1): 27
[Pubmed]  [Google Scholar] [DOI]
73 Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents
Hunsur Nagendra Nagesh,Kalaga Mahalakshmi Naidu,Damarla Harika Rao,Jonnalagadda Padma Sridevi,Dharmarajan Sriram,Perumal Yogeeswari,Kondapalli Venkata Gowri Chandra Sekhar
Bioorganic & Medicinal Chemistry Letters. 2013;
[Pubmed]  [Google Scholar] [DOI]
74 Whole-Cell Screening-Based Identification of Inhibitors against the Intraphagosomal Survival of Mycobacterium tuberculosis
Garima Khare,Praveen Kumar,Anil K. Tyagi
Antimicrobial Agents and Chemotherapy. 2013; 57(12): 6372
[Pubmed]  [Google Scholar] [DOI]

 

Read this article